Several clinical studies have shown that FGF-2 functions to exert anti-fibrotic effects under conditions as diverse as burns, chronic wounds, oral ulcers, vascular ulcers, diabetic ulcers, pressure ulcers, and surgical incisions49–52. The gene discussed is FGF2; the disease is decubitus ulcer.